pillbase.ru

POLIVY

Active substance: Polatuzumab vedotin

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · POLATUZUMAB VEDOTIN 140 mg/7.52mL

United StatesActive

Marketing holder: Genentech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • ПОЛАЙВИ®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 140 мг, 140 мг (original in Russian, GRLS)
    ЛП-006599
    Ф. Хоффманн-Ля Рош Лтд.
  • Полайви®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 140 мг, 140 мг (original in Russian, GRLS)
    ЛП-№(002088)-(РГ-RU)
    Ф.Хоффманн-Ля Рош Лтд
EU 1
  • Polivy
    polatuzumab vedotin
    EMEA/H/C/004870
    Roche Registration GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-45d7-710e-abd6-20d6d91cd89b,01a120c5-e510-7161-b0e7-1d7b2b67a96e;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-6003-75d2-9f62-6b39d3dd8627,01a12098-bc1b-7186-b41a-dbd3d2a914d3;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50242-105
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 50242-105 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50242-105 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50242-105 · Verified 2026-10-09 · open in source